Intrinsic Value of S&P & Nasdaq Contact Us

Homology Medicines, Inc. FIXX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
63/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.70
+188.9%

Homology Medicines, Inc. (FIXX) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 5 Buy, 4 Hold.

The consensus price target is $2.70, representing an upside of 188.9% from the current price $0.93.

FIXX Stock — 12-Month Price Forecast

$2.70
▲ +188.86% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Homology Medicines, Inc., the price target is $2.70.
The average price target represents a +188.86% change from the last price of $0.93.

FIXX Analyst Ratings

Buy
9
Ratings
5 Buy
4 Hold
Based on 9 analysts giving stock ratings to Homology Medicines, Inc. in the past 3 months
Rating breakdown
Buy
5 56%
Hold
4 44%
56%
Buy
5 analysts
44%
Hold
4 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message